New COVID-19 drug used to treat patients suffering from respiratory failure is in trials
Fox Business Apr. 07, 2021 – 5:06 – NeuroRX CEO Dr. Jonathan Javitt discusses the new COVID-19 drug for respiratory distress and vaccine boosters.
Fox Business Apr. 07, 2021 – 5:06 – NeuroRX CEO Dr. Jonathan Javitt discusses the new COVID-19 drug for respiratory distress and vaccine boosters.
Cheddar News – Apr 2, 2021 02:23 pm
Interview with Dr. Yo – Streamed live on Feb 11, 2021
University of Miami Health System